Trials / Conditions / Skin Infections, Bacterial
Skin Infections, Bacterial
8 registered clinical trials studyying Skin Infections, Bacterial.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Retapamulin Microdialysis Feasibility Study NCT01812382 | GlaxoSmithKline | Phase 1 |
| Completed | ALTARGO(Retapamulin) PMS(Post-marketing Surveillance) NCT01445600 | GlaxoSmithKline | — |
| Completed | GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection NCT01209078 | GlaxoSmithKline | Phase 2 |
| Completed | Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA NCT00852540 | Stiefel, a GSK Company | Phase 3 |
| Completed | United States Pharmacovigilence Retapamulin-Prescribing NCT01153880 | GlaxoSmithKline | — |
| Completed | Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) NCT00684177 | GlaxoSmithKline | Phase 3 |
| Completed | Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. NCT00555061 | GlaxoSmithKline | Phase 4 |
| Completed | Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo NCT00133874 | GlaxoSmithKline | Phase 3 |